Keywords: merck, co, inegy, outperforms, crestor, study, usa-based

Merck & Co's Inegy outperforms Crestor in study

Article | 26 June 2006

Print This

USA-based pharmaceutical company Merck & Co says that data from a trial of its product Inegy (ezetimibe/simvastin), shows that it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in